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Introduction
Cytochrome P450 (CYP) 2D6 is one of the most important isoforms due to its central role in the metabolism of a number of drugs such as opioids, antidepressants and neuroleptics. The genetic polymorphisms of CYP2D6 cause inter-individual difference in the efficacy and toxicity of drugs (Ingelman-Sundberg, 2005 ). An ethnic difference is found not only in the frequency of poor metabolizers (PMs) but also in the activity of debrisoquine hydroxylase within subjects categorized as apparent extensive metabolizers (EMs). The mean metabolic ratio for debrisoquine metabolism in an EM population has been reported to be slightly lower in Asians than in Caucasians. This seems to be caused by a higher frequency of individuals classified as intermediate metabolizers (IMs) showing reduced activities. In fact, the lower CYP2D6 activity in IMs is associated with the CYP2D6*10 allele (Tateishi et al., 1999) . The CYP2D6*10 allele contains a g.100C>T (where the A of the ATG start codon is +1) that causes a Pro34Ser amino acid substitution, leading to the formation of an unstable enzyme with lower metabolic activity (Nakamura et al., 2002) . The large variation of dextromethorphan O-demethylase activities has been observed even among subjects with CYP2D6*10 genotype (Tateishi et al., 1999) .
To clarify the causes of this variation, we previously investigated the CYP2D6 gene of 254 Japanese subjects and identified 5 novel non-synonymous SNPs (Soyama et al., 2004) . In the present study, we found one novel SNP associated with the CYP2D6*10 allele (CYP2D6*72) in an independent population of 349 individuals. We also found one previously identified CYP2D6*10 haplotype (CYP2D6*49). We clarified that these haplotypes were possible factors causing the impaired function of CYP2D6. This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods
Chemicals
Dextromethorphan and dextrorphan were purchased from Wako Pure Chemicals (Osaka, Japan). NADP + , glucose-6-phosphate and glucose-6-phosphate dehydrogenase were obtained from Oriental Yeast (Tokyo, Japan). All other chemicals were of the highest quality commercially available.
Subjects
A total of 349 unrelated healthy Japanese subjects, who received medical checkups in the Japanese Red Cross Society Kumamoto Health Care Center (Kumamoto, Japan), were recruited in this study. Liver samples were obtained as described previously (Yamaori et al., 2004) . Written informed consent was obtained from each subject. This study was approved by the Ethics Committees of Hokkaido University and Kumamoto University.
Genotyping for CYP2D6
Genomic DNA was prepared from peripheral leukocytes or liver samples according to the method of phenol-chloroform extraction followed by ethanol precipitation. Genotyping for the CYP2D6*5 and CYP2D6*1×2 alleles was carried out according to the method described by Johansson et al. (Johansson et al., 1996) . Detection of the other mutations was performed by the direct sequencing method described previously (Yamazaki et al., 2003) . (Iwata et al., 1998) . Each CYP2D6 together with CPR was expressed in Escherichia coli (E. coli) cells as described by Iwata et al. (Iwata et al., 1998) .
Enzyme sources
Microsomes from human livers were suspended in 10 mM Tris-HCl buffer (pH 7.4) containing 1.0 mM ethylenediaminetetraacetic acid and 20% (v/v) glycerol. Microsomal protein contents were determined using Pierce BCA Protein Assay Kit (Pierce Chemical, Rockford, IL, USA) with bovine serum albumin as a standard.
Measurement of dextromethorphan O-demethylase activity
Dextromethorphan O-demethylase activity was determined according to the method as described below. A typical incubation mixture consisted of the membrane fraction of E. coli expressing CYP2D6 (50 pmol/mL) or human liver microsomes (0.2 mg protein/mL), dextromethorphan (3.5-400 µM) and an NADPH-generating system (0.5 mM NADP + , 5 mM glucose 6-phosphate and 1 unit/mL glucose phosphate dehydrogenase) and 50 mM potassium phosphate buffer (pH 7.4). After 15 min incubation at 37°C, the reaction was terminated by addition of 10 µL of 60% (w/v) HClO 4 . Protein Kinetic parameters for the dextromethorphan O-demethylation were estimated with a computer program (Microcal Origin, Microcal Software, Northampton, MA, USA) designed for a nonlinear regression analysis. Statistical comparisons were made with Dunnett's post hoc test using StatView v5.0 (SAS Institute, Cary, NC), and differences were considered to be statistically significant when the p value was < 0.05.
Results and Discussion
Novel SNP of g.3318G>A, causing amino acid substitution (E383K), was discovered by sequencing of the CYP2D6 gene locus containing in the 5'-flanking region, all exons and introns, and (Soyama et al., 2004) , was also found in this 349 Japanese population.
To examine functional alterations caused by F120I and E383K, we examined dextromethorphan O-demethylase activities of wild-and mutant-type CYP2D6 expressed in E. coli membrane ( Table 1 ).
The K m values of recombinant CYP2D6.49 and CYP2D6.72 for dextromethorphan O-demethylation were significantly higher than that of wild-type CYP2D6.1. CYP2D6.49 also showed significantly higher K m value compared to that of CYP2D6.10. The V max /K m of CYP2D6.10 was approximately 30-fold lower than that of CYP2D6.1, consistent with previous findings (Ramamoorthy et al., 2001 ).
Thus, the V max /K m values of CYP2D6.49 and CYP2D6.72 were 16% and 42% of that of CYP2D6.10, and 0.5% and 1.3% of CYP2D6.1, respectively. CYP2D6.49 and CYP2D6.72 showed V max /K m values of 1.3% and 1.5% relative to CYP2D6.1 for bufuralol 1'-hydroxylation, and 9.9% and 11.6% for debrisoquine 4-hydroxylation (data not shown).
To investigate whether or not the novel genetic polymorphisms influenced the catalytic activities of CYP2D6 in hepatic microsomes, dextromethorphan O-demethylase activities of liver microsomes from subjects carrying different CYP2D6 genotypes were measured ( Table 2) Interestingly, a new peak, suggesting the formation of a new metabolite eluted at approximately 18 min, was seen when dextromethorphan was incubated with E. coli membrane expressing CYP2D6.49 (data not shown). In liquid chromatography mass spectrometry (LC/ MS) analysis, an [M+H] + ion at 288 was observed for the new metabolite, demonstrating an addition of 16 units (a hydroxyl group) to dextromethorphan (MW = 271) (data not shown). Although information on the position of the hydroxyl group of dextromethorphan was not sufficient in the present study, the parent ion for the new metabolite appeared to correspond to 7-hydroxydextromethorphan, as recently described concerning CYP2D6.1 with substitution of F120A by site-directed mutagenesis (Flanagan et al., 2004) . Since an authentic standard for 7-hydroxydextromethorphan was not available, we expressed the hydroxylation velocity as the peak area ratio of metabolite to the dextrorphan standard, because UV or fluorescence responses of dextromethorphan and dextrorphan were similar in our preliminary experiments. The K m and V max values for 7-hydroxylation were comparable to O-demethylation of dextromethorphan (Table 1 ). The 7-hydroxydextromethorphan was produced by liver microsomes from subjects carrying the CYP2D6*10/*49 genotype as an approximately 5-min peak as well as in CYP2D6.49 expressed in the E. coli (Fig. 1) . However, this peak was not detected in human liver microsomes prepared from subjects carrying other genotypes. Apparent K m , V max and V max /K m values for the formation of 7-hydroxydextromethorphan were calculated to be 107 µM, 139
pmol/min/mg protein and 1.3 µL/min/mg protein, respectively, with human liver microsomes (data not shown).
To further confirm the contribution of CYP2D6.49 in the dextromethorphan hydroxylation, quinidine, a known typical and potent inhibitor of CYP2D6, was added to the reaction mixture.
This article has not been copyedited and formatted. The final version may differ from this version. We were able to explain one of the causes of a large inter-individual variation in CYP2D6 enzyme activity within CYP2D6*10 genotype group. This article has not been copyedited and formatted. The final version may differ from this version. 
